In Korea, drugs approved for AD include acetylcholinesterase inhibitors (AChEIs), such as donepezil, rivastigmine, and galantamine, and N-methyl-D-aspartate (NMDA) receptor antagonists, such as memantine. Here, ACHE is linked to Alzheimer disease.